Indications |
Ophthalmic Ocular hypertension, Open-angle glaucoma Adult: Instil 1 drop of a 0.005% solution once daily in the evening. |
Warnings / Precautions |
Do not use within 5 min of thiomersal-containing preparations. Aphakia or pseudophakia with torn posterior lens cap or anterior chamber lenses; risk factors for cystoid macular oedema; brittle or severe asthma; history of intraocular inflammation; inflammatory, neovascular, angle-closure or congenital glaucoma; pregnancy, lactation. Remove contact lenses during use. |
Adverse Reactions |
Brown pigmentation particularly in those with mixed-color irides; blepharitis, ocular irritation and pain; darkening, thickening and lengthening of eyelashes; localised oedema; conjunctival hyperaemia; transient punctate epithelial erosions; dyspnoea; exacerbation of asthma; local skin reactions; iritis; uveitis; darkening of palpebral skin. |
Mechanism of Actions |
Latanoprost, a synthetic analogue of prostaglandin F2a, reduces the IOP by increasing the outflow of aqueous humour. Absorption: Absorbed through the cornea; peak concentration in the aqueous humour is reached around 2 hr after administration. Metabolism: Rapidly hydrolised to biologically active latanoprost acid by esterases in the cornea. Excretion: Via urine. |
Storage Conditions |
Ophthalmic: Store unopened at 2-8°C and at <25°C for up to 6 wk after opening. |
ATC Classification |
S01EE01 - latanoprost ; Belongs to the class of prostaglandin analogues. Used in the treatment of glaucoma. |
Storage |
Ophthalmic: Store unopened at 2-8°C and at <25°C for up to 6 wk after opening. |
Available As |
|
Latanoprost
Post Review about Latanoprost Click here to cancel reply.
Latanoprost Containing Brands
Latanoprost is used in following diseases
Drug - Drug Interactions of Latanoprost
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.